An elegant study by Haringman et al. investigating arthroscopic synovial tissue biopsies from patients with RA (n = 88) participating in various clinical trials, showed that a reduction in the number of synovial sublining CD68+ macrophages correlated significantly with clinical improvement independently of the therapeutic strategy (23). The gene discussed is CD68; the disease is rheumatoid arthritis.